Find News

Filter articles

Applied Filters

Showing 331 to 340 of 360 results

US Supreme Court knocks back two medical device disputes


The US Supreme Court has rejected both Nautilus’s and Covidien’s attempt to reverse patent infringement judgments in two separate disputes centring on medical devices.

Nautilus’s Supreme Court petition bolstered by tech companies’ support


A group of technology companies has urged the US Supreme Court to re-hear the Nautilus v Biosig case, arguing that the US Court of Appeals for the Federal Circuit failed to apply the “reasonable certainty” standard for determining whether a patent claim is indefinite.

Abbott succeeds in grey goods injunction request


Abbott Laboratories has successfully obtained an injunction against a number of US retailers selling ‘grey good’ strips for diabetics that had been manufactured in Ireland and later sold in the US at a lower price.

ITC cannot halt transmission of digital files, Federal Circuit rules


Electronic transmissions of data do not count as “articles” under the 1930 Tariff Act and the International Trade Commission overstepped its mark in halting their transmission, the US Court of Appeals for the Federal Circuit has ruled.

Jawbone says Fitbit patent claims violate anti-competition laws


Wearable technology maker Jawbone has accused rival Fitbit of using patent litigation and “poaching” key employees to hurt it commercially in an anti-competition claim filed at a US court.

Fitbit requests triple damages in patent lawsuit


Wearable technology company Fitbit has accused competitor Aliphcom of infringing a number of its patents covering devices that record an individual’s fitness.

Federal Circuit rules in Medtronic and St. Jude patent rows


The US Court of Appeals for the Federal Circuit issued two separate judgments concerning the alleged infringement of a patent covering an access control mechanism for a wireless network by medical device makers Medtronic and St. Jude Medical.

LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche


There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.

Ariosa says the sky is not falling, so Federal Circuit decision must stand


Ariosa Diagnostics has urged the US Court of Appeals for the Federal Circuit to reject Sequenom’s en banc request, stating that behind its “sky is falling” rhetoric is really a demand for courts to revise the US Supreme Court’s two-part test in determining the eligibility of a patent.

US Supreme Court ends $1 billion patent dispute


The US Supreme Court has declined to hear manufacturer W L Gore & Associates’s request for clarity on whether US patent law stipulates that patent licensing agreements must be placed in writing.

Showing 331 to 340 of 360 results